LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
---|---|---|---|---|---|---|---|---|---|---|
MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 82.75 | 84.90 | 4383 | 8621 | 0.5084 | 0.8070 | MN20160318_Q02 | L09 |
MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 82.75 | 84.90 | 4613 | 8621 | 0.5351 | 0.8209 | MN20160318_Q02 | L09 |
MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 84.45 | 84.90 | 4255 | 8254 | 0.5155 | 0.8090 | MN20160318_Q02 | L07 |
MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 84.45 | 84.90 | 5048 | 8254 | 0.6115 | 0.8565 | MN20160318_Q02 | L07 |
MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 84.45 | 84.90 | 4459 | 8254 | 0.5402 | 0.8219 | MN20160318_Q02 | L09 |
MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 84.45 | 84.90 | 4745 | 8254 | 0.5748 | 0.8391 | MN20160318_Q02 | L09 |
MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 86.16 | 84.90 | 4322 | 8141 | 0.5308 | 0.8166 | MN20160318_Q02 | L07 |
MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 86.16 | 84.90 | 5202 | 8141 | 0.6389 | 0.8684 | MN20160318_Q02 | L07 |
MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 86.16 | 84.90 | 4507 | 8141 | 0.5536 | 0.8282 | MN20160318_Q02 | L09 |
MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 86.16 | 84.90 | 4869 | 8141 | 0.5980 | 0.8498 | MN20160318_Q02 | L09 |
MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 87.86 | 84.90 | 4207 | 7680 | 0.5478 | 0.8231 | MN20160318_Q02 | L07 |
MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 87.86 | 84.90 | 5341 | 7680 | 0.6954 | 0.8913 | MN20160318_Q02 | L07 |
MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 87.86 | 84.90 | 4212 | 7680 | 0.5484 | 0.8234 | MN20160318_Q02 | L09 |
MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 87.86 | 84.90 | 4976 | 7680 | 0.6479 | 0.8708 | MN20160318_Q02 | L09 |
MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 89.57 | 84.90 | 4319 | 7494 | 0.5763 | 0.8365 | MN20160318_Q02 | L07 |
MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 89.57 | 84.90 | 5435 | 7494 | 0.7252 | 0.9030 | MN20160318_Q02 | L07 |
MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 89.57 | 84.90 | 4417 | 7494 | 0.5894 | 0.8429 | MN20160318_Q02 | L09 |
MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 89.57 | 84.90 | 5088 | 7494 | 0.6789 | 0.8837 | MN20160318_Q02 | L09 |
MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 91.27 | 84.90 | 4288 | 7420 | 0.5779 | 0.8370 | MN20160318_Q02 | L07 |
MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 91.27 | 84.90 | 5564 | 7420 | 0.7499 | 0.9127 | MN20160318_Q02 | L07 |
MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 91.27 | 84.90 | 4089 | 7420 | 0.5511 | 0.8235 | MN20160318_Q02 | L09 |
MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 91.27 | 84.90 | 5239 | 7420 | 0.7061 | 0.8949 | MN20160318_Q02 | L09 |
MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 92.98 | 84.90 | 3819 | 7257 | 0.5262 | 0.8096 | MN20160318_Q02 | L07 |
MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 92.98 | 84.90 | 5672 | 7257 | 0.7815 | 0.9246 | MN20160318_Q02 | L07 |
MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 92.98 | 84.90 | 4185 | 7257 | 0.5766 | 0.8356 | MN20160318_Q02 | L09 |